Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer

Nasser K. Altorki, R. S. Keresztes, J. L. Port, D. M. Libby, R. J. Korst, D. B. Flieder, C. A. Ferrara, D. F. Yankelevitz, K. Subbaramaiah, M. W. Pasmantier, A. J. Dannenberg

Research output: Contribution to journalArticlepeer-review

256 Scopus citations

Fingerprint

Dive into the research topics of 'Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences